Close Menu

Bruker CEO Takes 20 Percent Pay Cut in ‘05 As Company Seeks $3M A Year Savings

Bruker BioSciences announced another round of cost-cutting and restructuring on Monday to save the company $3 million a year, and another $1 million next year.

Bruker will move all its German administrative and life science business activities to its site in Bremen, and its German nuclear, biological, and chemical detection business to its Leipzig site. Moreover, the UK operations of subsidiaries Bruker AXS and Bruker Daltonics will be combined into one, based in Coventry.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.